These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 2322292)
1. Inhibitory studies of mexiletine and dextromethorphan oxidation in human liver microsomes. Broly F; Libersa C; Lhermitte M; Dupuis B Biochem Pharmacol; 1990 Mar; 39(6):1045-53. PubMed ID: 2322292 [TBL] [Abstract][Full Text] [Related]
2. Stereoselective hydroxylation of mexiletine in human liver microsomes: implication of P450IID6--a preliminary report. Vandamme N; Broly F; Libersa C; Courseau C; Lhermitte M J Cardiovasc Pharmacol; 1993 Jan; 21(1):77-83. PubMed ID: 7678683 [TBL] [Abstract][Full Text] [Related]
3. Dextromethorphan O-demethylation in liver microsomes as a prototype reaction to monitor cytochrome P-450 db1 activity. Dayer P; Leemann T; Striberni R Clin Pharmacol Ther; 1989 Jan; 45(1):34-40. PubMed ID: 2910636 [TBL] [Abstract][Full Text] [Related]
4. The metabolism of mexiletine in relation to the debrisoquine/sparteine-type polymorphism of drug oxidation. Broly F; Vandamme N; Libersa C; Lhermitte M Br J Clin Pharmacol; 1991 Oct; 32(4):459-66. PubMed ID: 1958440 [TBL] [Abstract][Full Text] [Related]
5. The role of CYP2D6 in primary and secondary oxidative metabolism of dextromethorphan: in vitro studies using human liver microsomes. Kerry NL; Somogyi AA; Bochner F; Mikus G Br J Clin Pharmacol; 1994 Sep; 38(3):243-8. PubMed ID: 7826826 [TBL] [Abstract][Full Text] [Related]
6. Role of specific cytochrome P450 enzymes in the N-oxidation of the antiarrhythmic agent mexiletine. Labbé L; Abolfathi Z; Lessard E; Pakdel H; Beaune P; Turgeon J Xenobiotica; 2003 Jan; 33(1):13-25. PubMed ID: 12519691 [TBL] [Abstract][Full Text] [Related]
7. The inhibitory effect of amiodarone and desethylamiodarone on dextromethorphan O-demethylation in human and rat liver microsomes. Jaruratanasirikul S; Hortiwakul R J Pharm Pharmacol; 1994 Nov; 46(11):933-5. PubMed ID: 7897605 [TBL] [Abstract][Full Text] [Related]
8. Primary and secondary oxidative metabolism of dextromethorphan. In vitro studies with female Sprague-Dawley and Dark Agouti rat liver microsomes. Kerry NL; Somogyi AA; Mikus G; Bochner F Biochem Pharmacol; 1993 Feb; 45(4):833-9. PubMed ID: 8452558 [TBL] [Abstract][Full Text] [Related]
9. Inhibitory effects of psychotropic drugs on mexiletine metabolism in human liver microsomes: prediction of in vivo drug interactions. Hara Y; Nakajima M; Miyamoto KI; Yokoi T Xenobiotica; 2005 Jun; 35(6):549-60. PubMed ID: 16192107 [TBL] [Abstract][Full Text] [Related]
10. Characterization of dextromethorphan N-demethylation by human liver microsomes. Contribution of the cytochrome P450 3A (CYP3A) subfamily. Gorski JC; Jones DR; Wrighton SA; Hall SD Biochem Pharmacol; 1994 Jul; 48(1):173-82. PubMed ID: 8043020 [TBL] [Abstract][Full Text] [Related]
11. High-performance liquid chromatographic assays for bufuralol 1'-hydroxylase, debrisoquine 4-hydroxylase, and dextromethorphan O-demethylase in microsomes and purified cytochrome P-450 isozymes of human liver. Kronbach T; Mathys D; Gut J; Catin T; Meyer UA Anal Biochem; 1987 Apr; 162(1):24-32. PubMed ID: 3605590 [TBL] [Abstract][Full Text] [Related]
12. Timolol metabolism in human liver microsomes is mediated principally by CYP2D6. Volotinen M; Turpeinen M; Tolonen A; Uusitalo J; Mäenpää J; Pelkonen O Drug Metab Dispos; 2007 Jul; 35(7):1135-41. PubMed ID: 17431033 [TBL] [Abstract][Full Text] [Related]
13. Xenobiotic and endobiotic inhibitors of cytochrome P-450dbl function, the target of the debrisoquine/sparteine type polymorphism. Fonne-Pfister R; Meyer UA Biochem Pharmacol; 1988 Oct; 37(20):3829-35. PubMed ID: 2903741 [TBL] [Abstract][Full Text] [Related]
14. The effect of cimetidine on dextromethorphan O-demethylase activity of human liver microsomes and recombinant CYP2D6. Madeira M; Levine M; Chang TK; Mirfazaelian A; Bellward GD Drug Metab Dispos; 2004 Apr; 32(4):460-7. PubMed ID: 16680870 [TBL] [Abstract][Full Text] [Related]
15. Use of quinidine inhibition to define the role of the sparteine/debrisoquine cytochrome P450 in metoprolol oxidation by human liver microsomes. Otton SV; Crewe HK; Lennard MS; Tucker GT; Woods HF J Pharmacol Exp Ther; 1988 Oct; 247(1):242-7. PubMed ID: 3171974 [TBL] [Abstract][Full Text] [Related]
16. Potent inhibition of yeast-expressed CYP2D6 by dihydroquinidine, quinidine, and its metabolites. Ching MS; Blake CL; Ghabrial H; Ellis SW; Lennard MS; Tucker GT; Smallwood RA Biochem Pharmacol; 1995 Sep; 50(6):833-7. PubMed ID: 7575645 [TBL] [Abstract][Full Text] [Related]
17. Identification of human liver cytochrome P450 enzymes that metabolize the nonsedating antihistamine loratadine. Formation of descarboethoxyloratadine by CYP3A4 and CYP2D6. Yumibe N; Huie K; Chen KJ; Snow M; Clement RP; Cayen MN Biochem Pharmacol; 1996 Jan; 51(2):165-72. PubMed ID: 8615885 [TBL] [Abstract][Full Text] [Related]
18. [In vitro tests of hepatic oxidation in man, predictive of drug interactions]. Dayer P; Leemann T; Striberni R; Meyer P Schweiz Med Wochenschr; 1987 Dec; 117(49):1971-3. PubMed ID: 3423780 [TBL] [Abstract][Full Text] [Related]
19. Inhibitory effects of anticancer drugs on dextromethorphan-O-demethylase activity in human liver microsomes. Le Guellec C; Lacarelle B; Catalin J; Durand A Cancer Chemother Pharmacol; 1993; 32(6):491-5. PubMed ID: 8258200 [TBL] [Abstract][Full Text] [Related]
20. CYP2D6- and CYP3A-dependent metabolism of dextromethorphan in humans. Jacqz-Aigrain E; Funck-Brentano C; Cresteil T Pharmacogenetics; 1993 Aug; 3(4):197-204. PubMed ID: 8220439 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]